<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>uc_FIDO: unambiguous characterization of food interactions with drugs ontology</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Constantine W. Spyrou</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Dept. of Food Science UC Davis Davis</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>CA cwspyrou@ucdavis.edu</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Matthew C. Lange</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Dept. of Food Science UC Davis Davis</institution>
          ,
          <addr-line>CA</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>- uc_FIDO is an ontology that unambiguously characterizes food interactions with drugs in the human body. This ontology is part of a group of food ontologies describing food and the human experience at the International Center for Food Ontology Operability, Data and Semantics (IC-FOODS) at UC Davis. The first of its kind, uc_FIDO characterizes relations between food, medicine, and human health. uc_FIDO brings together several existing ontologies related to anatomy, metabolic pathways, biological processes, drug ingredients and food structures. Through these ontologies, uc_FIDO annotates relationships between food and drug bioactives, human physiological conditions, and biological reaction pathways. Relationships that link together fully characterize various food interactions with drugs and their effects.</p>
      </abstract>
      <kwd-group>
        <kwd>bioactive</kwd>
        <kwd>interaction</kwd>
        <kwd>metabolic process</kwd>
        <kwd>active drug ingredient</kwd>
        <kwd>food component</kwd>
        <kwd>food matrix</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>I. INTRODUCTION (MOTIVATION AND INTENDED USAGE)
Approximately seven percent of hospitalizations are the
result of adverse drug reactions [1], many of which occur
between drugs and food. Past research clarifies these
potentially deadly reactions between our food and medicine.
Examples include interactions between grapefruit and drugs
which alter pathways involving cytochrome P450 (CytP450).
Drugs such as Lipitor (atorvastatin, a cholesterol-lowering
drug) were found in dangerously high concentrations in the
bloodstream when consumed with grapefruit juice [2]. Drugs
also limit nutrient absorption from many foods.
Corticosteroids, for example, are linked to increased calcium
excretion from the body [3]. These examples merely highlight
the broad array of effects and sources involved in food-drug
interactions. Much research has been undertaken, yet no
knowledge repository captures the scope of food-drug related
interactions, adverse, favorable, or otherwise. uc_FIDO
provides a platform upon which development of ecosystems of
consumer tools surrounding foods, drugs, and education can be
built to unify information resources. This will be crucial in</p>
      <p>Active ingredients primarily compose the class
hierarchy drawn from drug and food ontologies. However,
because uc_FIDO is intended as a knowledge source for
consumer-friendly tools, features like brands become necessary
to define as sub-classes. Because of the multiple properties of
different foods based on food matrices, concentrations of
nutrients in different ingredients (ie. Skim milk vs. whole
milk), each food becomes a specific class with multiple
subclasses relating to that food. For example, the class
“sourdough” would have subclasses relating to ingredients
(“all-purpose_flour”), recipes, bioactive molecules, and
nutrition content. Bioactive molecules and nutrients react with
drug bioactives in the human body, and thus are crucial to
mapping out defined interactions.</p>
      <p>
        The location and stimuli of human body reactions require
full comprehension. Understanding these is crucial to building
uc_FIDO. Specifically, most reactions occur in the blood
stream, the blood-brain barrier, and in organs. Defining these
reactions, nutrient cycles, and biological pathways that are
affected by these potential interactions is crucial. Biological
pathways are much more complex based on anatomy and
location. uc_FIDO draws from Uberon as a class resource for
anatomical structures and locations, while Reactome integrates
base ontologies of biological pathways [
        <xref ref-type="bibr" rid="ref8">9</xref>
        ]. From here, human
body reaction pathways like “sensory_process” or
“mechanical_food_breakdown” and anatomical locations
including “lung”, “alveoli”, and others, become key classes
that link to where drug and food bioactive compounds are
metabolized by physiological location and anatomical
structures where reactions occur. Through properties like
physiological location and common reactants or products,
interactions are defined by linking together different bioactives
and conditions. For example, the class
“bloodstream_interaction” links to the classes “Lipitor” and
“Grapefruit” through sharing the property “has_location
bloodstream”.
      </p>
      <p>B. Ontology Mapping</p>
      <p>Mapping of uc_FIDO was undertaken similarly to
Joslin’s One-Carbon Metabolism map [10]. CMAPs
initially mapped food drug interactions split into three
components – food, drugs, and body reaction pathways.</p>
      <p>Figure 1 above shows CMAPs effectively creating
generalized previews of uc_FIDO. Each class of human
body reactions above has subclasses like disease states,
concentrations, and pH levels that all factor into whether
reactions within food drug interactions will take place.</p>
    </sec>
    <sec id="sec-2">
      <title>When translating the concept map into linkages and</title>
      <p>
        classes in Protégé, many extra subclasses are considered.
Because of several potential sites of food-drug interactions
[
        <xref ref-type="bibr" rid="ref10">11</xref>
        ], these must be taken into account when mapping out
classes of interactions in base ontologies. Figure 2 below
shows some subclasses considered because of the possible
locations of food-drug interactions.
      </p>
    </sec>
    <sec id="sec-3">
      <title>Linkages of these subclasses occur through sharing</title>
      <p>properties including anatomical location and reactant or
product molecules. The sharing of properties between
interactions, anatomical structures, and bioactive pathway
sites allows for accurate mapping of where and how these
interactions occur, along with their effects.</p>
      <p>III. RESULTS AND ANALYSIS</p>
      <p>
        The completion of uc_FIDO requires base ontologies
currently under construction. Specifically, ontologies
surrounding food need to be more developed. While several
ontologies regarding food are progressing [
        <xref ref-type="bibr" rid="ref10">11</xref>
        ], no current food
ontology takes into account all different types of bioactive
compounds found in foods. Ingredients and food additives have
been taken into account in some cases, but pesticides, natural
food toxins, and other bioactives also need to be considered as
they may have effects on drug efficacy or pharmacological
effects. Additional factors (ie. other supplements or foods
consumed) also factor into drug concentration bloodstreams,
contributing to a network of multiple simultaneous interactions
that requires further research. uc_FIDO is a great start for
mapping relationships between drugs and other substances
intravenous or extraneous to the human body, such as food.
However, more ontologies need development to describe the
relationship between nutrients and genes [10] or ontologies that
understand how food and nutrients affect biological pathways
and human reactions, along with other food related ontologies.
When these ontologies are completed, actions of food and
drugs within human bodies can be realized in a clean,
easy-touse ontology.
      </p>
      <p>While uc_FIDO continues to be developed under
ICFOODS, ontologies described in the above paragraphs relating
to all chemicals present in food and nutrient-gene interactions
(among others) can be developed. When all IC-FOODS
ontologies are completed, they can power multiple consumer
and medical Internet applications that inform and promote
quicker responses to food emergencies while increasing access
to food education information.</p>
    </sec>
    <sec id="sec-4">
      <title>REFERENCES</title>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          <string-name>
            <given-names>Jason</given-names>
            <surname>Lazarou</surname>
          </string-name>
          ,
          <string-name>
            <surname>Bruce H. Pomeranz</surname>
            , and
            <given-names>Paul N.</given-names>
          </string-name>
          <string-name>
            <surname>Corey</surname>
          </string-name>
          , “
          <article-title>Incidence of Adverse Drug Events in Hospitalized Patients: A Meta-Analysis of Prospective Studies,”</article-title>
          <string-name>
            <given-names>J.</given-names>
            <surname>Am</surname>
          </string-name>
          . Med. Assoc., vol.
          <volume>279</volume>
          , no.
          <issue>15</issue>
          , pp.
          <fpage>1200</fpage>
          -
          <lpage>1205</lpage>
          , May
          <year>1998</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          <string-name>
            <given-names>Irina</given-names>
            <surname>Piatkov</surname>
          </string-name>
          , Trudi Jones, and
          <string-name>
            <surname>Mark</surname>
            <given-names>McLean</given-names>
          </string-name>
          , “Drug Interactions, Pharmacogenomics and Cardiovascular Complication,” Intech,
          <year>2013</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          <string-name>
            <given-names>RM</given-names>
            <surname>Carney</surname>
          </string-name>
          ,
          <article-title>KE Freedland, EH Rubin, MW Rich, BC Steinmeyer, and WS Harris, “Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial</article-title>
          .,
          <source>” J. Am. Med</source>
          . Assoc., vol.
          <volume>302</volume>
          , no.
          <issue>15</issue>
          , pp.
          <fpage>1651</fpage>
          -
          <lpage>1657</lpage>
          , Oct.
          <year>2009</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          <string-name>
            <surname>Matthew C Lange</surname>
          </string-name>
          , Danielle G Lemay,
          <article-title>and J Bruce German, “A Multiontology Framework to Guide Agriculture and Food towards Diet and Health,”</article-title>
          <string-name>
            <given-names>J. Sci. Food</given-names>
            <surname>Agric</surname>
          </string-name>
          ., vol.
          <volume>87</volume>
          , pp.
          <fpage>1427</fpage>
          -
          <lpage>1434</lpage>
          , Apr.
          <year>2007</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          [5]
          <string-name>
            <given-names>Unknown</given-names>
            <surname>Author</surname>
          </string-name>
          , “DrON Chebi.” Unpublished.,
          <year>2015</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          <string-name>
            <given-names>Kimiya</given-names>
            <surname>Taji and Matthew C. Lange</surname>
          </string-name>
          , “uc_Eating:
          <article-title>Ontology for unambigious characterization of eating and food habits</article-title>
          .” Unpublished.,
          <fpage>01</fpage>
          -Jul-
          <year>2016</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          <string-name>
            <given-names>F</given-names>
            <surname>Bellisle</surname>
          </string-name>
          , “
          <article-title>Why should we study human food intake behaviour?,”</article-title>
          <string-name>
            <surname>Nutr. Metab. Cardiovasc. Dis.</surname>
          </string-name>
          , vol.
          <volume>13</volume>
          , no.
          <issue>4</issue>
          , pp.
          <fpage>189</fpage>
          -
          <lpage>193</lpage>
          , Aug.
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>[9] “Reactome BioPathway Software.” Unpublished.</mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          <string-name>
            <given-names>A. C.</given-names>
            <surname>Joslin</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Green</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. B.</given-names>
            <surname>German</surname>
          </string-name>
          , and
          <string-name>
            <given-names>M. C.</given-names>
            <surname>Lange</surname>
          </string-name>
          , “
          <article-title>Concept mapping One-Carbon Metabolism to model future ontologies for nutrient-gene-phenotype interactions,” Genes Nutr</article-title>
          ., vol.
          <volume>9</volume>
          , no.
          <issue>5</issue>
          ,
          <string-name>
            <surname>Sep</surname>
          </string-name>
          .
          <year>2014</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>
          [11]
          <string-name>
            <surname>Maged</surname>
            <given-names>N. Kamel</given-names>
          </string-name>
          <string-name>
            <surname>Boulos</surname>
          </string-name>
          , Abdulslam Yassine, Shervin Shirmohammadi, Chakkrit Snae Namahoot, and Michael Bruckner, “
          <article-title>Towards an 'Internet of Food': Food Ontologies for the Internet of Things,” Future Internet</article-title>
          , vol.
          <volume>7</volume>
          , pp.
          <fpage>372</fpage>
          -
          <lpage>392</lpage>
          , Oct.
          <year>2015</year>
          .
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>